Anti-Spike Antibody Responses in Allogeneic Stem Cell Transplant Recipients to Two Doses of COVID-19 mRNA Vaccination: A Retrospective, Single-Center Analysis

Allogeneic hematopoietic stem cell transplantation (allo-HSCT) recipients were excluded from the initial SARS-CoV-2 mRNA vaccination efficacy trials. Suboptimal vaccine responses have been reported in immunocompromised cohorts such as patients with solid tumors or hematologic malignancies, suggestin...

Descripción completa

Detalles Bibliográficos
Autores principales: Shahan, Jaime L., Collins, Robert H., Patel, Prapti, Madanat, Yazan F., Vusirikala, Madhuri
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Harborside Press LLC 2023
Materias:
Research & Scholarship
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10414532/
https://www.ncbi.nlm.nih.gov/pubmed/37576365
http://dx.doi.org/10.6004/jadpro.2023.14.5.2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10414532/
https://www.ncbi.nlm.nih.gov/pubmed/37576365
http://dx.doi.org/10.6004/jadpro.2023.14.5.2

Ejemplares similares